Dolby Laboratories (DLB)
(Delayed Data from NYSE)
$69.19 USD
-1.49 (-2.11%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $69.17 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Company Summary
Founded in 1965, San Francisco, CA-based Dolby Laboratories, Inc develops audio and imaging technologies that revolutionise entertainment for user-generated content, TV shows, films, music, and gaming.
A majority of the company’s revenues are derived from the licensing of audio technologies. The company operates on various licensing models including a two-tier model, an integrated licensing model, a patent licensing model, recoveries and collaboration arrangements.
Apart from this, the company also generates revenue from licensing of consumer imaging technologies and audio and imaging technologies for premium cinema offerings in partnership with exhibitors. Apart ...
Company Summary
Founded in 1965, San Francisco, CA-based Dolby Laboratories, Inc develops audio and imaging technologies that revolutionise entertainment for user-generated content, TV shows, films, music, and gaming.
A majority of the company’s revenues are derived from the licensing of audio technologies. The company operates on various licensing models including a two-tier model, an integrated licensing model, a patent licensing model, recoveries and collaboration arrangements.
Apart from this, the company also generates revenue from licensing of consumer imaging technologies and audio and imaging technologies for premium cinema offerings in partnership with exhibitors. Apart from its licensing business, the company also provide products and services for a range of applications in the broadcast and movie theatre markets.
Dolby also offers solutions to companies to create real-time digital experiences that boost audience engagement.
Currently, Dolby is focusing on expanding its product portfolio and has already developed new applications for voice conferencing and imaging solutions that enable HDR picture quality in televisions and cinemas. Some of the newly introduced products include Dolby Voice, Dolby Vision and Dolby Cinema.
The company reports under two operating segments — Licensing (92.5% of total revenues in third-quarter fiscal 2024) and Products and Services (7.5%).
In the third quarter of fiscal 2024, the Broadcast market represented 36% of total licensing revenues. Mobile Licensing, Consumer Electronics, PC Licensing and Licensing from Other Markets accounted for 11%, 10%, 15%, and 19% of licensing revenues, respectively.
General Information
Dolby Laboratories
1275 MARKET STREET
SAN FRANCISCO, CA 94103
Phone: 415-558-0200
Fax: 415-645-4000
Web: http://www.dolby.com
Email: investor@dolby.com
Industry | Audio Video Production |
Sector | Consumer Discretionary |
Fiscal Year End | September |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 11/21/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.69 |
Current Year EPS Consensus Estimate | 3.69 |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | 11/21/2024 |
Price and Volume Information
Zacks Rank | ![]() |
Yesterday's Close | 70.68 |
52 Week High | 90.06 |
52 Week Low | 66.35 |
Beta | 0.97 |
20 Day Moving Average | 666,163.88 |
Target Price Consensus | 99.00 |
4 Week | -3.47 |
12 Week | -10.55 |
YTD | -17.99 |
4 Week | -9.07 |
12 Week | -12.16 |
YTD | -29.13 |
Shares Outstanding (millions) | 95.35 |
Market Capitalization (millions) | 6,739.17 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 1.70% |
Annual Dividend | $1.20 |
Payout Ratio | 0.46 |
Change in Payout Ratio | 0.06 |
Last Dividend Payout / Amount | 8/19/2024 / $NA |
Fundamental Ratios
P/E (F1) | 19.17 |
Trailing 12 Months | 19.42 |
PEG Ratio | NA |
vs. Previous Year | 46.88% |
vs. Previous Quarter | -53.47% |
vs. Previous Year | -3.20% |
vs. Previous Quarter | -20.77% |
Price/Book | 2.75 |
Price/Cash Flow | 19.29 |
Price / Sales | 5.35 |
6/30/24 | 10.66 |
3/31/24 | 10.15 |
12/31/23 | 10.21 |
6/30/24 | 8.59 |
3/31/24 | 8.10 |
12/31/23 | 8.22 |
6/30/24 | 4.14 |
3/31/24 | 3.50 |
12/31/23 | 3.68 |
6/30/24 | 4.04 |
3/31/24 | 3.42 |
12/31/23 | 3.59 |
6/30/24 | 20.36 |
3/31/24 | 19.10 |
12/31/23 | 18.89 |
6/30/24 | 16.87 |
3/31/24 | 15.00 |
12/31/23 | 14.70 |
6/30/24 | 20.78 |
3/31/24 | 18.55 |
12/31/23 | 18.03 |
6/30/24 | 25.67 |
3/31/24 | 25.44 |
12/31/23 | 24.72 |
6/30/24 | 3.95 |
3/31/24 | 4.18 |
12/31/23 | 4.42 |
6/30/24 | 0.00 |
3/31/24 | 0.00 |
12/31/23 | 0.00 |
6/30/24 | 0.00 |
3/31/24 | 0.00 |
12/31/23 | 0.00 |